Pharma & Biotech

NextCure's equity continues its upward trajectory, building on recent momentum within the biotechnology sector. The company's stock concluded Friday's session...

Chemomab Therapeutics shares are currently trading at $2.70, following a session where prices moved narrowly between $2.64 and $2.70. Despite...

vTv Therapeutics is navigating a complex period marked by significant changes to its equity structure that are directly impacting market...

Synlogic's stock continues to struggle within a pronounced downward trend. The biotechnology company's shares declined by 1.78% during Friday's session,...

Viking Therapeutics has captured significant market attention with its recent stock performance, demonstrating strong upward momentum following analyst confirmation of...

ICU Medical's stock experienced a substantial decline on Friday, dropping 7% to close at $117.77 per share. This significant sell-off...

Following its transition to private ownership, Paratek Pharmaceuticals has executed a significant strategic move by acquiring Optinose in May 2025....

The volatile nature of biotechnology investing was on full display this week as Harmony Biosciences Holdings saw its equity value...

After experiencing a prolonged downward trend, Eli Lilly has staged a remarkable market recovery. The pharmaceutical giant's stock surged back...

Bayer AG faces mounting legal pressure after the Missouri Supreme Court declined to hear the pharmaceutical giant's appeal of a...